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MATERIALS AND METHODS
Cohort study
Patients. In a consecutive cohort of patients who
underwent surgery from September 1990 to February
2001 for disease of the first segment of the subclavian
artery, data were collected prospectively for demographics,
risk factors, symptoms, angiographic findings, and postop-
erative results.
Surgical technique. Surgery was performed with
general anesthesia by using a horizontal supraclavicular
incision. If a carotid endarterectomy was necessary, this
procedure was done first, extending the incision along the
anterior border of the sternocleidomastoid muscle.
Patients received Dextran 40, 100 mL bolus in 20 minutes
and 20 mL/hr, for a total of 500 mL. Carotid endarterec-
tomies were performed after the administration of 5000
units of heparin, before clamping the carotid artery, and
with the routine use of a shunt. The omohyoid muscle was
not divided, but retracted craniad. The subclavian artery
and its branches were dissected after mobilization of the
phrenic nerve and transection of the scalenus anterior
muscle. On the right, the first segment of the subclavian
artery was crossed anteriorly by the ansa subclavia, which
was preserved with the recurrent laryngeal nerve. On the
left, the thoracic duct, and on the right, the lymphatic
Reconstruction of the first and second segments of the
subclavian artery may be required to treat aneurysmal dis-
ease and, more frequently, occlusive disease. Several tech-
niques are available, including transthoracic bypass
grafting1,2 or endarterectomy,3-5 subclavian-carotid trans-
position (SCT),6-8 and extrathoracic bypass grafting
(carotid-subclavian, carotid-axillary, axillary-axillary, and
subclavian-subclavian).1,9-12 The transthoracic approach is
invasive and is rarely used in this elderly population
because of the high incidence of complications.13 Carotid
subclavian carotid bypass grafting (CSB) and SCT are the
interventions used by most surgeons.
In this study, we report on a consecutive cohort of
patients treated with SCT and the results of a systematic
review of the literature comparing SCT and CSB.
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Purpose: We describe outcomes in a cohort of patients undergoing subclavian carotid transposition (SCT) for occlusive
disease of the first segment of the subclavian artery and perform a systematic review of the literature on SCT and
carotid subclavian bypass grafting (CSB).
Methods: Relevance, validity and extraction of review results were done in duplicate. Data were collected prospectively
in our consecutive cohort of patients.
Results: From September 1990 to February 2001, we performed 27 SCTs, four for aneurysmal disease and 23 for
occlusive disease. SCTs done for aneurysms were excluded from the current analysis. In patients with occlusive disease,
the primary indications for surgery were vertebrobasilar and carotid symptoms (10, 44%), vertebrobasilar insufficiency
(7, 30%), vertebrobasilar and arm symptoms (4, 17%), carotid symptoms (1, 4%), and vertebrobasilar, carotid, and arm
symptoms (1, 4%). An SCT was performed in conjunction with an endarterectomy of the carotid artery in 12 patients
(52%), with an endarterectomy of the subclavian artery in seven patients (30%), and with an endarterectomy of the ver-
tebral artery in six patients (26%). A lymph leak complicated two surgeries (9%). In our series, patients improved clin-
ically after surgery, and reconstructions were all found to be patent by means of Doppler ultrasound scanning at a mean
follow-up of 25 ± 21 months. Three patients (13%) died during follow-up of complications of coronary artery disease.
From 1966 to 2000, 516 patients who underwent CSB and 511 patients who underwent a SCT were reported in the
literature. Patency rates were 84% and 98%, respectively (P < .0001; absolute risk reduction, 15%; number-needed-to-
treat-differently, 7), and the rates of freedom from symptoms were 88% and 99%, respectively, at a mean follow-up of
59 ± 17 months (range, 1-228 months).
Conclusion: Our cohort study showed that SCT is safe and effective for reconstruction of the first segment of the sub-
clavian artery. The systematic review suggested that rates of patency and freedom from clinical symptoms are higher
with SCT than with CSB. (J Vasc Surg 2002;35:422-9.)
trunk were identified and divided. This allowed mobiliza-
tion and retraction of the jugular vein anteriorly and access
to the common carotid artery (Figure). To obtain an ade-
quate length, the subclavian artery was transected to as
proximal a location as possible. The proximal stump of the
subclavian artery was closed with two running sutures of
4-0 prolene and two horizontal mattress sutures rein-
forced with Teflon pledgets. The anterior wall of the sub-
clavian artery was divided longitudinally to the level of the
vertebral artery only when an endarterectomy of this
artery was necessary for stenosis or occlusion. Heparin
(5000 units) was administered intravenously before
clamping the carotid and the subclavian arteries. The anas-
tomosis between the subclavian and the carotid artery was
performed with 6-0 prolene, with attention to avoiding
tension at this point. Embolization of air and debris into
the cerebral circulation was avoided by means of a careful
technique throughout.
Outcomes. Patients were followed up clinically and
with duplex scanning every 6 months for 1 year and yearly
thereafter. A standard questionnaire for new onset of
symptoms was used, and the treating physician assessed
patency with a clinical examination and bilateral arm
blood pressure measurement. The duplex scanning was
performed in a vascular laboratory not involved in the
study.
Analysis. Data were analyzed by using Arcus
QuickStatBiomedical software version 1.0 (Longman, UK).
Systematic review
Search strategy. Reports of SCT and CSB were iden-
tified through a Medline database search from 1966 to
September 2000 by using Ovid software (Ovid
Technologies, New York, NY) and the search strategy out-
lined in the appendix.
Inclusion criteria. Studies were selected for review
when they met the criteria of elective carotid-to-subclavian
bypass grafting or subclavian-to-carotid transposition for
occlusive disease of the first segment of the subclavian
artery. Exclusion criteria included: studies in which the
indication for intervention was aneurysm, trauma, neo-
plastic disease, or vascular malformation; studies with
fewer than five patients; reports of carotid-to-contralateral
subclavian revascularization, extra-anatomic bypass graft-
ing, isolated vertebral artery reconstructions, or revascu-
larization with endovascular techniques; studies that did
not report the patency rate; and duplicate publications.
Relevance and validity. A review of titles and
abstracts identified potentially relevant studies, which were
then retrieved so that the final decision of relevance was
made on the basis of the full text. Studies were reviewed
in duplicate for relevance and for internal validity
(methodological rigor). The latter was evaluated by using
a series of pre-specified questions assessing the type and
direction of inquiry (randomized controlled trial, retro-
spective or prospective cohort study), the documentation
of demographics, the description of the intervention, and
the assessment of outcome.
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A, The left subclavian artery lies in close proximity to the com-
mon carotid artery. B, The left subclavian artery is anastomosed
to the carotid artery. C, The right subclavian artery is anasto-
mosed to the carotid artery. 1, Carotid artery; 2, subclavian
artery; 3, vertebral artery; 4, thyrocervical artery; 5, internal tho-
racic artery; 6, vagus nerve; 7, phrenic nerve; 8, ansa subclavia.
A
B
C
Data extraction. A standardized form was used by
two independent reviewers (A.L., H.S.) to collect data.
Details of study design, patient selection, baseline charac-
teristics, symptoms, surgical procedures, co-interventions,
follow-up, and outcome assessment were recorded in
duplicate. Disagreements were resolved by means of con-
sensus (A.L., H.S., C.S.C.).
Types of outcome measure. In selecting outcomes
for inclusion in this review, we considered these facts: (1)
the theoretical advantage of SCT versus bypass grafting is
an improvement in hemodynamics and possibly patency
rate; (2) SCT may be technically more demanding and
possibly associated with a higher incidence of complica-
tions; (3) this surgery is performed as a means of relieving
symptoms and possibly preventing strokes. No validated
scales to assess improvement of symptoms were reported
in the literature, which allowed objective comparison of
results of the two different techniques. On the basis of the
available data, we felt that the overall net benefit of a spe-
cific surgical technique was best captured by means of the
outcome cumulative patency rate. Secondary outcomes
studied were the surgeon’s reporting of clinical improve-
ment, perioperative mortality rate, stroke occurrence, or
local complications.
Statistical analysis
Agreement between reviewers was assessed by means
of Cohen’s kappa statistic.14 The kappa statistic was calcu-
lated with Arcus QuickStatBiomedical software version
1.0. To summarize results of across studies, we assumed
lack of statistically significant heterogeneity. For each out-
come, the sum of the total number of events divided by
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the total number of patients gave a pooled estimate
weighted by study size. Proportions and 95% CIs were cal-
culated by using GraphPad StatMate software version
1.01 (GraphPad Software, San Diego, Calif) and chi-
square and Fisher exact tests as a means of comparing pro-
portions for the two different interventions with Arcus
QuickStat Biomedical software version 1.0. P values equal
to or less than .05 were considered to be statistically sig-
nificant, and all tests were two-tailed.
RESULTS
Cohort study
Seventy-two patients were examined for disease of the
subclavian artery in an 11-year period, and 27 underwent
surgery (38%), 23 for occlusive disease and four for
aneurysmal disease. The latter were excluded from this
analysis. In the 45 patients with occlusion of the subcla-
vian artery who were treated conservatively, symptoms
were not present or not severe enough to require surgery.
The population was elderly, with a mean age of 69 ± 7
years; men and women were equally represented. Table I
illustrates the demographics and presenting complaints.
The indications for surgery were vertebrobasilar, carotid,
or arm symptoms, alone or in association (Table I).
Patients were examined with duplex scanning and aortic
arch angiography. Multilevel occlusive disease involving the
ipsilateral carotid or the contralateral carotid and vertebral
or subclavian arteries was present in 20 patients (87%); two
extracranial cerebral arteries were involved in six patients
(26%), three extracranial cerebral arteries were involved in
eight patients (35%), and four extracranial cerebral arteries
were involved in six patients (26%). A stenosis greater than
50% of both carotid arteries was present in 10 patients
(44%), a stenosis greater than 50% of the ipsilateral artery
was present in 15 patients (65%), and a stenosis of greater
than 50% of the contralateral artery was present in 13
patients (57%). Only five patients (22%) had no carotid
stenosis. Table II illustrates the severity and the distribu-
tion of the stenoses in the extracranial cerebral arteries.
An SCT was performed in conjunction with an
endarterectomy of the carotid artery in 12 patients (52%),
in conjunction with an endarterectomy of the subclavian
artery in seven patients (30%), and in conjunction with an
endarterectomy of the vertebral artery in six patients (26%;
Table III). There were no perioperative deaths or strokes.
All reconstructions remained patent, and patients were free
of symptoms at a mean follow-up of 25 ± 21 months.
Complications were few; they included one hematoma
(4%), which resolved with conservative treatment, and two
lymphatic leaks (9%) that required re-exploration. During
follow-up, three patients (13%) died of complications of
coronary artery disease at 6, 7, and 8 years.
Systematic review
Search results. Titles and abstracts of 58 studies were
obtained with our search strategy and reviewed for studies
that met inclusion and exclusion criteria. Thirty-one pub-
Table I. Demographics, symptoms and indications for
surgery: cohort study
Patients N (%)
Demographics
Male sex 12 (52)
Smoking history 22 (96)
Coronary artery disease 3 (13)
Arrhythmia 1 (4)
Hypertension 12 (52)
Diabetes mellitus 5 (22)
Symptoms
Dizziness 21 (91)
Syncope 10 (44)
Visual disturbances 8 (35)
Global amnesia 1 (4)
Amaurosis fugax 5 (22)
Transient ischemic attacks 4 (17)
Stroke 1 (4)
Arm claudication/pain 5 (22)
Primary indication for surgery
Vertebrobasilar and carotid symptoms 10 (44)
Vertebrobasilar symptoms 7 (30)
Vertebrobasilar and arm symptoms 4 (17)
Vertebrobasilar, carotid, and arm symptoms 1 (4)
Carotid symptoms alone 1 (4)
Arm symptoms alone 0
lications were assessed in full text, and 19 relevant publi-
cations were identified.
Relevance and validity. Interobserver reliability for
judgement of relevance was good, with a Cohen’s kappa
statistic of 0.80. The final decisions about methodologic
quality of each publication’s description of study design,
patient population, and intervention are summarized in
Table IV. An adequate description of patient demograph-
ics was present in 14 studies (73%), and an adequate
description of the intervention used was present in 11
studies (58%). Interobserver agreement for decisions
related to methodologic quality was excellent for the
description of study design (kappa, 0.89), good for the
description of patient demographics (kappa, 0.62), and
poor for the description of surgical intervention (kappa,
0.20). There were no randomized controlled trials. All
studies were retrospective; it was generally not clear
whether consecutive patients were reported. The main
outcome, patency, was reported in all studies.
Patients. Patients undergoing surgery either for CSB
or SCT were younger than those in our series, with mean
age of 59 ± 2 years. Demographics, indications for surgery,
and adjunctive procedures were similar in patients under-
going SCT and patients undergoing CSB (Table V).
Patency. SCT was performed in 511 patients, with a
patency rate of 99% (95% CI, 97%-100%) at a mean fol-
low-up of 61 ± 15 months (range, 1-192 months), and
CSB was performed in 516 patients, with a patency rate
of 84% (95% CI, 80%-87%) at a mean follow-up of 58 ±
18 months (range, 1-228 months; chi-square, 69; P <
.0001). The cumulative patency rate for the CSB with
synthetic grafts was 86% (95% CI, 83%-89%) at a mean
follow-up of 58 ± 18 months (range, 1-228 months),
and the cumulative patency rate for CSB with veins was
74% (95% CI, 62%-83%) at a mean follow-up of 49 ± 9
months (range, 1-192 months; chi-square, 11.7; P =
.0006; Table IV).
Other outcomes. Freedom from symptoms was
achieved in 99% (95% CI, 98%-99%) of the SCT group
and in 88% (95% CI, 88%-91%) of the CSB group (chi-
square, 53.6; P < .0001). The CSB group exhibited a sta-
tistically significant higher incidence of early postoperative
occlusions compared with the SCT group (chi-square,
6.0; P = .01). In patients undergoing SCT, the relative risk
reduction of postoperative thrombosis was 74.6%, com-
pared with patients undergoing CSB, and the absolute risk
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reduction was 2.6%, which corresponds to a number-
needed-to-treat-differently (NNTD) of 38 (ie, 38 patients
need to be treated with a SCT instead of a CSB to prevent
1 postoperative thrombosis). The difference between all
other complications, including nerve injuries, was not sig-
nificantly different (Table VI).
DISCUSSION
The results of this cohort study show that SCT is a safe
and effective procedure for treating occlusive disease of
the first segment of the subclavian artery. The review of
the literature provided evidence that the short- and long-
term patency rates are superior to those of CSB. Thirty-
eight patients needed to be treated with SCT rather than
CSB to prevent an early postoperative thrombosis. At 5
years, the absolute risk reduction of occlusion is 15%. This
corresponds to an NNTD of only 7 (ie, only 7 patients
need to undergo a SCT to prevent 1 occlusion at 5 years).
CSB with venous conduits exhibited a lower patency rate
than CSB performed with synthetic grafts. This finding
may be attributed to smaller size, kinks, or angulations in
the bypass grafting segment, which are perhaps more likely
with venous conduits.
The available data on the prevalence of occlusive dis-
ease of the first segment of the subclavian artery was
derived from cohort studies of selected patients referred to
tertiary vascular centers.15,16 In 4748 angiograms per-
formed for signs and symptoms of ischemic cerebrovascu-
lar disease, the prevalence of stenosis greater than 30% was
21% (95% CI, 20%-22%), and the prevalence of occlusion
was 3% (95% CI, 2.8%-3.9%).17 Sterpetti15 reported that,
Table II. Distribution and severity of extracranial arterial cerebral occlusive disease: cohort study
Subclavian artery Carotid artery Vertebral artery
(Number of arteries)
Stenosis % Right Left Right Left Right Left
50-89 0 1 10 9 1 4
> 90 2 3 3 4 0 0
100 2 15 1 1 6 1
Table III. Subclavian carotid transposition and adjunc-
tive procedures: cohort study
Patients N (%)
SCT alone 9 (35)
SCT and CE 5 (19)
SCT, CE, and VE 1 (4)
SCT, CE, and SE 3 (12)
SCT, CE, SE, and VE 3 (12)
SCT, SE, and VE 1 (4)
SCT and VE 1 (4)
SCT, Subclavian transposition; CE, carotid endarterectomy; VE, vertebral
endarterectomy; SE, subclavian endarterectomy.
compared with the number of carotid endarterectomies,
subclavian artery reconstructions represented 4.6% (95%
CI, 3.4%-6.1%) of surgeries. In our experience, SCTs were
5.1% (95% CI, 3.3%-7.6%) compared with carotid
endarterectomies and were performed in 32% (95% CI,
21%-44%) of all patients who underwent assessment for
occlusive disease of the subclavian artery. The true preva-
lence of subclavian stenosis is difficult to estimate because
many patients have no symptoms. In patients with disease
of the subclavian artery that is demonstrated by means of
angiography, only 24% (95% CI, 23%-25%) had symp-
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toms.16 Moreover, reversal of flow in the vertebral artery
correlates poorly with symptoms.18 One reason for the
rarity of symptoms in subclavian artery occlusive disease
may be the rich collateral network and the slow progres-
sion of subclavian artery stenoses.19 Increasing severity of
stenosis was noted by means of ultrasound scanning in
17% of patients in 2 years of follow-up.19 Despite the rel-
ative unusual occurrence of symptomatic occlusive disease
of the first segment of the subclavian artery, in some
patients this problem leads to debilitating symptoms that
often remain unrecognized.
Table IV. Characteristics of studies included in the systematic review
Adequate Adequate 
documentation of description of Follow-up, Patency rate, % 
Author, Year Patients demographics N (%) intervention N (%) Mean (range) (95% CI)
Subclavian carotid transposition
Total 511 61 (1-192) 99 (97-1.0)*
Sterpetti,15 1989 16 yes yes 46.9 (2-148) 100
Edwards,32 1994 178 – – 31 (1-131) 99
Van der Vielt,33 1995 21 yes – 64 (3-192) 100
Ziomedek,34 1986 5 – yes 52 100
Law,35 1995 9 yes yes 60 100
Kretschmer,36 1991 32 yes – 120 100
Deriu,37 1998 20 yes – 72 100
Laurian,38 1998 51 yes yes 54.5 (1-148) 96
Schardey,39 1996 108 yes yes 70 (1-144) 100
Mehigan,40 1978 12 – yes 48 100
Sandman,41 1980 59 – yes 48 95
Carotid subclavian bypass grafting
Total 516 58 (1-228) 84 (80-87)*
With vein
Total 76 49 (1-192) 74 (62-83)†
Sterpetti,15 1989 6 yes yes 46.9 (2-148) 100
Van der Vielt,33 1995 15 yes – 64 (3-192) 53
Ziomedek,34 1986 13 – yes 52 53
Wittwer,42 1998 1 yes – 61 (1-130) 0
Sullivan,43 1996 3 – – 37.1 (1-92) 100
Defraigne,9 1990 15 yes yes 40 93
Law,35 1995 11 yes yes 60 64
Maggissano,2 1981 4 yes yes 100
Salam,44 1993 6 yes – 38.4 (2-118) 93
Perler,45 1990 2 yes – 42 (1-121) 100
With synthetic graft
Total 440 58 (1-228) 86 (83-89)†
Sterpetti,15 1989 24 yes yes 46.9 (2-124) 83
Edwards,32 1994 9 – – 31 (1-132) 44
Van der Vielt,33 1995 6 yes – 64 (3-192 50
Ziomedek,34 1986 18 – yes 52 94
Wittwer,42 1998 39 yes – 61 (1-134) 84
Sullivan,43 1996 4 – – 37.1 (1-92) 50
Defraigne,9 1990 14 yes yes 40 93
Law,35 1995 40 yes yes 60 93
Maggissano,2 1981 24 yes yes (1-72) 88
Vitti,46 1994 124 yes yes (5-164) 94
Salam,44 1993 22 yes – 38.4 (1-118) 95
Kretschmer,36 1991 19 yes – 120 74
Perler,45 1990 26 yes – 42 (1-121) 85
Deriu,37 1998 20 yes – 72 65
AbuRahma,47 2000 51 yes yes 92.4 (12-228) 92
*Patency of subclavian carotid transposition compared with carotid subclavian bypass, χ2 = 69 (P < .0001).
†Patency of carotid subclavian bypass with vein compared with carotid subclavian bypass with graft, χ2 = 11.7 (P = .0006).
Carotid disease is frequently associated with subclavian
stenoses.20 The presence of multilevel diseases involving
the ipsilateral and contralateral carotid and vertebral arter-
ies has been reported in 58%9 to 76% of cases.15 In this
cohort, multilevel disease was identified in 87% of patients,
and a stenosis greater than 50% of the ipsilateral or con-
tralateral carotid was present in 18 patients (78%), 12
(52%) of whom had symptoms.
Arm claudication was the primary indication for
surgery in 44% (95% CI, 41%-47%) of patients reported in
the literature and in none of the patients in this series,
reflecting our philosophy of conservative management of
chronic ischemia of the upper limbs.
Endarterectomy for associated cerebral artery occlu-
sive disease is readily attainable with SCT and may explain
the greater clinical improvement achieved compared with
CSB. Carotid endarterectomy may be performed by
means of a simple extension of the horizontal incision
along the anterior border of the sternocleidomastoid mus-
cle. In this series, more patients (52%) underwent a
carotid endarterectomy than in series reported in the liter-
ature (18%; 95% CI, 15%-21%), without a corresponding
increase in perioperative complications. We also per-
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formed endarterectomy of the subclavian artery in 30% of
patients and of the vertebral artery in 26% of patients.
The hemodynamics of SCT may be superior to those
of CSB. In the former, blood flow is always prograde. In
CSB, blood flows in a retrograde manner from the subcla-
vian anastomosis to the vertebral artery, possibly generat-
ing turbulent flow. Moreover, the existence of a blind
segment of subclavian artery, proximal to the subclavian
anastomosis, creates the potential for thrombosis of that
segment of subclavian artery and, therefore, of the verte-
bral artery that originates from it.21 A steal phenomenon
of blood from the carotid to the subclavian artery occur-
ring after surgery (“carotid steal”) is also possible.22 A
reduction in blood flow in the carotid artery after CSB has
been observed in animal models.23-25 Only three cases of
clinically significant carotid steal, however, were reported,
two after CSB26,27 and one after a carotid-axillary bypass
grafting procedure.28 In patients undergoing an SCT,
Sandman21 was unable to identify hemodynamic evidence
of carotid steal with Doppler ultrasound scanning during
surgery. Theoretically, carotid steal may be precipitated by
a concurrent severe stenosis in the carotid artery, which
increases the resistance in this vascular bed. Blood will
Table V. Demographics of subclavian carotid transposition and bypass grafting: systematic review
Bypass grafting n/N (%) Transposition n/N (%)
Demographics
Male sex 182/355 (51) 225/431 (52)
Smoking history 372/476 (78) 153/248 (62)
Coronary artery disease 191/408 (46) 105/248 (42)
Hypertension 240/469 (51) 116/248 (47)
Diabetes mellitus 69/476 (14) 21/248 (8)
Primary indication for surgery
Vertebrobasilar symptoms alone 251/507 (50) 283/502 (56)
Vertebrobasilar and carotid symptoms 29/303 (6) 10/26 (38)
Vertebrobasilar and arm symptoms 89/331 (27) 7/26 (27)
Vertebrobasilar, arm, and carotid symptoms 40/303 (13) 0/26 (0)
Carotid symptoms alone 128/507 (25) 53/443 (12)
Arm symptoms alone 193/516 (37) 228/443 (51)
Combined carotid endarterectomy 90/432 (21) 59/399 (15)
The denominator changes between demographics and outcomes because not all data were reported by all studies.
n, Numerator; N, denominator.
Table VI. Mortality and morbidity of subclavian carotid transposition and bypass grafting: systematic review
Bypass grafting n/N (%) Transposition n/N (%)
30 days mortality 6/507 (1.2) 6/511 (1.2)
Mortality during follow-up 59/409 (14.4) 64/415 (15.4)
Nerve injury 46/500 (9.2) 51/452 (11.2)
Stroke 33/500 (6.6) 20/452 (4.4)
Lymphatic leak 10/472 (2.1) 11/452 (2.4)
Postoperative thrombosis* 16/460 (3.5) 4/452 (0.9)
Graft infection 5/428 (1.2) 0
Hematoma 3/381 (0.8) 4/452 (0.9)
The denominator changes between demographics and outcomes because not all data were reported by all studies.
*Bypass grafting compared with transposition, χ2 = 6.0 (P = .01).
n, Numerator; N, denominator.
then preferentially flow through the path of least resist-
ance, the subclavian artery. A number of authors23,29,30
emphasize the potential benefit of a carotid endarterec-
tomy in the presence of a significant carotid stenosis
before revascularization of the subclavian artery. A strategy
of simultaneous correction of a hemodynamically signifi-
cant carotid stenosis (> 70%) also offers the potential ben-
efit of preventing thrombosis of the stenosed carotid at the
time of surgery. A similar predisposition to carotid throm-
bosis also exists when a carotid endarterectomy is per-
formed before SCT or CSB, and we attempted prophylaxis
for this by administering a second bolus of heparin and
with the concomitant use of platelet inhibitors.
Despite the perception that SCT is technically more
difficult than bypass grafting, the incidence of periopera-
tive complications does not bare this out; the incidence of
nerve injuries, hematomas, and lymphatic leaks was similar
with both techniques. Vascular infections, however, did
not occur in patients undergoing SCT and were present
(graft infections) in 1% of CSB reported in the literature.
A reduction in operative time, blood loss, and length of
hospital stay with SCT, compared with CSB, was reported
by a number of authors who directly compared the two
procedures.15,31,32
Interpretation of the results of this study is limited by
the quality of the studies included. All were retrospective,
the patency rate was not always confirmed with objective
tests, and no studies included an assessment of clinical out-
comes by an independent observer. Potential biases, there-
fore, may be introduced at a number of levels, weakening
the inferences that may be drawn. Theoretical constructs,
however, support the results of this work.
CONCLUSION
Our experience and the results of the review of the lit-
erature confirmed that SCT was superior to CSB in
patency rate and long-term clinical improvement. SCT has
the advantage of being an anatomic reconstruction that
allows physiologic blood flow separation and hemody-
namics at the level of the anastomosis and does not require
the use of grafts with their attendant complications (infec-
tions, kinks, aneurysms). SCT should be considered the
intervention of choice in the practice of vascular surgeons
who deal with occlusive disease of the first segment of the
subclavian and vertebral arteries.
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Appendix. Search strategy
[(SUBCLAVIAN ARTERY and CAROTID ARTERY
DISEASE) and (by-pass or transposition) or (Subclavian
carotid bypass or carotid subclavian bypass or subclavian
carotid transposition or carotid subclavian transposition)].
Capitals are used to indicate pre-exploded Medical
Subject Headings/coding terms, and lower case is used to
indicate text words.
The reference lists of all relevant articles, the reference
lists of review articles, and the authors’ personal files were
also searched.
